This clinical trial aims to evaluate user sensory experiences and smoking behavior when using IQOS heated tobacco products (HTPs) among adults who smoke cigarettes.
Adults 21-65 years
Adults who smoke (defined as ≥ 5 days weekly use of either menthol or non-menthol cigarettes over the past 3 months)
Willing to provide informed consent and abstain from using nicotine products 12 hours before each visit
Willing to bring UBC to each study visit
Current use of other non-combustible nicotine products (e.g., electronic [e]-cigarettes, HTPs; [defined as ≥ 5 days weekly use in the past 30 days])
Planning to quit nicotine use and/or use of any smoking cessation medication in the past 30 days
Current diagnosis of any lung diseases (e.g., asthma, cystic fibrosis, or chronic obstructive pulmonary disease)
Self-reported unstable or significant psychiatric conditions (past/stable conditions will be allowed)
Ohio State University Comprehensive Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator